Anti-Muc1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in Vivo Ovarian Cancer Model
PLoS ONE - United States
doi 10.1371/journal.pone.0024405
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 9, 2011
Authors
Publisher
Public Library of Science (PLoS)